Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2025	Dec. 31, 2024
Condensed Consolidated Statements of Operations [Abstract]
Net sales	$ 167,697,000	$ 186,176,000	$ 577,531,000	$ 564,249,000
Cost of goods sold	134,819,000	141,294,000	468,009,000	448,916,000
Gross profit	32,878,000	44,882,000	109,522,000	115,333,000
Operating expenses:
General and administrative	15,328,000	16,212,000	45,094,000	47,934,000
Sales and marketing	6,350,000	5,621,000	19,371,000	16,904,000
Research and development	3,460,000	3,008,000	10,694,000	7,884,000
Foreign exchange impact of lease liabilities and forward contracts	(594,000)	2,460,000	(10,411,000)	18,966,000
Total operating expenses	24,544,000	27,301,000	64,748,000	91,688,000
Operating income	8,334,000	17,581,000	44,774,000	23,645,000
Other expenses:
Interest expense, net	10,901,000	14,435,000	36,412,000	43,004,000
Change in fair value of compound net derivative liability	(3,910,000)	(260,000)	140,000	(2,460,000)
Total other expenses	6,991,000	14,175,000	36,552,000	40,544,000
Income (loss) before income tax (benefit) expense	1,343,000	3,406,000	8,222,000	(16,899,000)
Income tax (benefit) expense	(434,000)	1,115,000	5,552,000	1,849,000
Net income (loss)	$ 1,777,000	$ 2,291,000	$ 2,670,000	$ (18,748,000)
Basic net income (loss) per share (in Dollars per share)	$ 0.09	$ 0.12	$ 0.14	$ (0.95)
Diluted net income (loss) per share (in Dollars per share)	$ 0.09	$ 0.11	$ 0.13	$ (0.95)
Weighted average number of shares outstanding:
Basic (in Shares)	19,393,228	19,783,170	19,377,401	19,739,481
Diluted (in Shares)	20,139,201	20,416,958	20,146,118	19,739,481